147 related articles for article (PubMed ID: 37475642)
1. Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study.
Shang Y; Widman L; Ebrahimi F; Ludvigsson JF; Hagström H; Wester A
Liver Int; 2023 Oct; 43(10):2142-2152. PubMed ID: 37475642
[TBL] [Abstract][Full Text] [Related]
2. Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study.
Ebrahimi F; Simon TG; Hagström H; Söderling J; Wester A; Roelstraete B; Ludvigsson JF
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3346-3355.e19. PubMed ID: 37245712
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.
Simon TG; Roelstraete B; Hartjes K; Shah U; Khalili H; Arnell H; Ludvigsson JF
J Hepatol; 2021 Nov; 75(5):1034-1041. PubMed ID: 34224779
[TBL] [Abstract][Full Text] [Related]
4. Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study.
Wester A; Hagström H
J Intern Med; 2022 Sep; 292(3):492-500. PubMed ID: 35373876
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
6. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
[TBL] [Abstract][Full Text] [Related]
7. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.
Simon TG; Roelstraete B; Khalili H; Hagström H; Ludvigsson JF
Gut; 2021 Jul; 70(7):1375-1382. PubMed ID: 33037056
[TBL] [Abstract][Full Text] [Related]
8. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study.
Chen YG; Yang CW; Chung CH; Ho CL; Chen WL; Chien WC
Hepatol Int; 2022 Aug; 16(4):807-816. PubMed ID: 35064545
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
[TBL] [Abstract][Full Text] [Related]
10. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
Han AL
BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk factors in non-alcoholic fatty liver disease.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
Liver Int; 2019 Jan; 39(1):197-204. PubMed ID: 30253056
[TBL] [Abstract][Full Text] [Related]
15. Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.
Zhang T; Zhang Y; Zhang C; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
PLoS One; 2014; 9(5):e96651. PubMed ID: 24801211
[TBL] [Abstract][Full Text] [Related]
16. Increased risk for microvascular outcomes in NAFLD-A nationwide, population-based cohort study.
Ebert T; Widman L; Stenvinkel P; Hagström H
J Intern Med; 2023 Aug; 294(2):216-227. PubMed ID: 37259481
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan.
Wei YT; Lee PY; Lin CY; Chen HJ; Lin CC; Wu JS; Chang YF; Wu CL; Guo HR
BMC Gastroenterol; 2020 Feb; 20(1):32. PubMed ID: 32041532
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study.
Wu S; Yuan C; Yang Z; Liu S; Zhang Q; Zhang S; Zhu S
BMC Med; 2022 Aug; 20(1):262. PubMed ID: 35989356
[TBL] [Abstract][Full Text] [Related]
19. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract][Full Text] [Related]
20. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
